Free Trial
OTCMKTS:VLRXQ

Valeritas (VLRXQ) Stock Price, News & Analysis

Valeritas logo
$0.02 0.00 (0.00%)
As of 07/1/2020

About Valeritas Stock (OTCMKTS:VLRXQ)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.02
52-Week Range
$0.01
$4.28
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

Receive VLRXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valeritas and its competitors with MarketBeat's FREE daily newsletter.

VLRXQ Stock News Headlines

Valeritas Holdings Inc (VLRXQ)
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
See More Headlines

VLRXQ Stock Analysis - Frequently Asked Questions

Valeritas' stock was trading at $0.02 on January 1st, 2025. Since then, VLRXQ shares have increased by 0.0% and is now trading at $0.02.
View the best growth stocks for 2025 here
.

Valeritas Holdings, Inc. (OTCMKTS:VLRXQ) released its quarterly earnings data on Tuesday, November, 12th. The company reported ($1.91) earnings per share for the quarter, beating the consensus estimate of ($2.52) by $0.61. The company had revenue of $8.46 million for the quarter.

Shares of VLRXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/12/2019
Today
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:VLRXQ
Employees
125
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:VLRXQ) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners